Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
Drug Resistance, Carbapenem-Resistant Enterobacteriaceae Infection, Sepsis
About this trial
This is an interventional treatment trial for Drug Resistance focused on measuring Pharmacokinetics/Pharmacodynamics, Antibiotic combination regimens, Dose-optimization, Carbapenem-Resistant Enterobacteriaceae Infection
Eligibility Criteria
Inclusion Criteria:
- Any patients are diagnosed any diseases caused by CRE infection by physicians at Phramongkutklao hospital during 1/4/2018 to 30/4/2021.
- Any patients are more than 18 years old.
Any patients have at least 1 criterion as following 3.1 Any patients have at least 2 of the signs and symptoms of Systemic inflammatory response syndrome (SIRS), including
- Fever (temperature > 38 °C) or hypothermia (temperature < 36°C)
- Tachypnea (heart rate > 90 beats per minute)
- Respiratory rate > 20 beats per minute or Paco2 < 32 mm Hg (4.3 kPa)
- White blood cell count > 12,000 cells per millilitre (leukocytosis) or < 4,000 cells per milliliter (leukopenia) 3.2. Any patients are diagnosed with sepsis or have ≥ 2 points of Sequential Organ Failure Assessment (SOFA) Score or qSOFA (Quick SOFA) Score.
3.3. Any patients are diagnosed with septic shock or are received vasopressors (eg, dopamine, norepinephrine, epinephrine, vasopressin, phenylephrine), mean arterial pressure (MAP) < 65 mm Hg, and lactate > 2 mmol/L (18 mg/dL) 3.4 Any patients are received mechanical ventilation 3.5 Any patients are admitted at ICU ward.
Exclusion Criteria:
- Patients are breast-feeding or pregnancy.
- Patients are insufficient or incomplete information on the medical electronic record such as patients transferred.
Sites / Locations
- Phramongkutklao hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Optimal antibiotic combination regimens
Standard antibiotic regimens
The patients in the groups will be given the optimal antibiotic combination regimens.
The patients in the groups will be given the standard antibiotic regimens.